Biochem Biophys Res Commun
- PERFILOVA KV, Matyuta IO, Minyaev ME, Boyko KM, et al
High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2
nucleoprotein variant with improved replicative fitness.
Biochem Biophys Res Commun. 2025;767:151915.
J Gen Virol
- AHMED MN, Abu Habib US, Abdallah AM, Emara MM, et al
The impact of pre-existing immunity on the emergence of within-host immune-escape
mutations in Omicron lineages.
J Gen Virol. 2025;106:002108.
J Immunol
- NOURI HR, Schaunaman N, Kraft M, Numata M, et al
Tollip deficiency enhances mitophagy and reduces STING activation in influenza A
virus-infected mice.
J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
J Infect Dis
- ZHU S, Quint J, Leon T, Sun M, et al
Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza
Using Linked Public Health Information Systems, California, 2023-2024 Season.
J Infect Dis. 2025 May 13:jiaf248. doi: 10.1093.
J Virol
- KOUTSAKOS M, Reynaldi A, Aban M, Barr IG, et al
Binding antibody titers against the hemagglutinin and neuraminidase correlate
with protection against medically attended influenza A and B disease.
J Virol. 2025 May 13:e0039125. doi: 10.1128/jvi.00391.
J Virol Methods
- WU JS, Kan JY, Chang YS, Phuong Le UN, et al
Developing Zika virus-transduced hACE2 expression models for severe acute
respiratory syndrome coronavirus 2 infection in vitro and in vivo.
J Virol Methods. 2025 Apr 14:115166. doi: 10.1016/j.jviromet.2025.115166.
- PUGLIA I, Caporale M, Di Teodoro G, Spedicato M, et al
Optimization of an infectious subgenomic amplicons reverse genetics protocol for
the rescue of synthetic coronaviruses.
J Virol Methods. 2025;336:115152.
PLoS Comput Biol
- FERRAZ MVF, Adan WCS, Lima TE, Santos AJC, et al
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting
assisted by molecular simulation and machine learning.
PLoS Comput Biol. 2025;21:e1012921.
PLoS One
- STEPHENS CR, Gutierrez JP
A conceptual and computational framework for modeling the complex, adaptive
dynamics of epidemics: The case of the SARS-CoV-2 pandemic in Mexico.
PLoS One. 2025;20:e0323473.
- KIM SH, Jung M
Disentangling behavioral determinants of seasonal influenza vaccination in
post-corona era: An integrated model approach.
PLoS One. 2025;20:e0323184.
- SZNAJDER KK, Legro RS, Teti D, Mackeen AD, et al
Maternal and infant health during the COVID-19 pandemic - A Pennsylvania Study
Protocol.
PLoS One. 2025;20:e0323891.
- GAUFFIN K, Ostergren O, Cederstrom A
The global response to the pandemic: An empirical cluster analysis of policies
targeting COVID-19.
PLoS One. 2025;20:e0322692.
- THAKKAR V, Silverman GM, Kc A, Ingraham NE, et al
A comparative analysis of large language models versus traditional information
extraction methods for real-world evidence of patient symptomatology in acute and
post-acute sequelae of SARS-CoV-2.
PLoS One. 2025;20:e0323535.
- LAWRENCE MR, Arnetz JE, Counts SE, Ahmed A, et al
Self-reported health, neuropsychological tests and biomarkers in fully recovered
COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study.
PLoS One. 2025;20:e0315486.
- SANCHEZ CODEZ MI, Benavente Fernandez I, Moyer K, Leber AL, et al
The differential burden of acute rhinovirus infections in children with
underlying conditions.
PLoS One. 2025;20:e0313237.
- JACOBS M, Haelermans C, Meeter M
Effective remediation programs for vulnerable students to overcome learning loss.
PLoS One. 2025;20:e0323352.
- BUSZKIEWICZ JH, Tseng AS, Dai J, Ismach A, et al
Association between early-pandemic food assistance use and subsequent food
security trajectories among households in Washington State during the first three
years of the COVID-19 pandemic.
PLoS One. 2025;20:e0321585.
- KAWASE A, Fukushige M
Expectations regarding the effectiveness of mask-wearing and pandemic fatigue:
The experience in Japan.
PLoS One. 2025;20:e0321402.
- FAQIHI F, Perri R, Chien J, Cho JG, et al
Universal health care delivery mitigates socioeconomic-related risk for adverse
outcomes in hospitalised patients: Lessons from the COVID-19 pandemic in
Australia.
PLoS One. 2025;20:e0322780.
- XIA Z, Meng J, Wang X, Liu P, et al
Efficacy of BCG vaccination against COVID-19 in health care workers and
non-health care workers: A meta-analysis of randomized controlled trials.
PLoS One. 2025;20:e0321511.
- SINGH-VERDEFLOR KD, Kelly MM, DeMuri GP, Warner G, et al
Differences in COVID-19 testing perceptions among caregivers of children with
medical complexity by rurality.
PLoS One. 2025;20:e0323651.
- KANERVA M, Rautava K, Kurvinen T, Marttila H, et al
Economic impact and disease burden of COVID-19 in a tertiary care hospital: A
three-year analysis.
PLoS One. 2025;20:e0323200.
- ABRAMOVA D, Haase PM, Just AM, Frank S, et al
Impact of prior SARS-CoV-2 infection on perioperative cardiac, pulmonary and
neurocognitive complications in older patients: Study protocol for an observative
case control study.
PLoS One. 2025;20:e0323599.
- BEISSAT K, Lattard V, Picard-Meyer E, Fafournoux A, et al
Infectious potential and circulation of SARS-CoV-2 in wild rats.
PLoS One. 2025;20:e0316882.
- NKHATA A, Shi X, Zhang Y, Chen H, et al
Construction and application of SARS-CoV-2 protein ontology (CoVPO).
PLoS One. 2025;20:e0317589.
- LIN YE, Chien LY, Hu ML
The relationships among nurses' spiritual health, sleep quality, and stress and
the factors influencing stress during the late global COVID-19 pandemic: A cross-
sectional study.
PLoS One. 2025;20:e0323164.
- YANG MJ, Gaulin M, Seegert N, Fan Y, et al
What drives the effectiveness of social distancing in combating COVID-19 across
U.S. states?
PLoS One. 2025;20:e0308244.
- HASAN MB, Hossain MN, Khatun H, Uddin GS, et al
Using smart transportation assets to hedge fossil energy markets: Evidence from
quantile-based VAR approach.
PLoS One. 2025;20:e0317748.
- SOARES P, Gomez V, Gaio V, Santos JA, et al
A protocol for high-dose quadrivalent influenza vaccine effectiveness in the
community and long-term care facilities using electronic health records.
PLoS One. 2025;20:e0314177.
- DELGADO-ALONSO C, Matias-Guiu JA, Alvarado JM, Diez-Cirarda M, et al
Computerized neuropsychological assessment in post-COVID condition.
PLoS One. 2025;20:e0322304.
- NOVELLI S, Reinkemeyer C, Bulaev D, O'Sullivan MP, et al
Waning of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19
pandemic in 2020: A 12-month-evaluation in three population-based European
studies.
PLoS One. 2025;20:e0320196.
- WANG H, Lu L, Liu Z, Sun Y, et al
Study on measurement and prediction of agricultural product supply chain
resilience based on improved EW-TOPSIS and GM (1,1)-Markov models under public
emergencies.
PLoS One. 2025;20:e0321248.
- LUKASCHEK K, Hentschel H, Rottenkolber M, Alberer M, et al
Association of mental health, quality of life, and SARS-CoV-2 infection in
individuals in need of care: Results from a multicentre registry study.
PLoS One. 2025;20:e0323017.
- TURNER MM, Jang Y, Heo R, Ye Q, et al
Mask wearing as a prosocial behavior: Proposing and testing the moral norms
activation model.
PLoS One. 2025;20:e0322921.
- GIERTHMUEHLEN M, Gierthmuehlen PC
COVIVA: Effect of transcutaneous auricular vagal nerve stimulation on
fatigue-syndrome in patients with Long Covid - A placebo-controlled pilot study
protocol.
PLoS One. 2025;20:e0315606.
Vaccine
- FRANCIS MJ
A rapid human vaccine process development map outlining lessons learnt from
ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic.
Vaccine. 2025;55:127040.
- BLACKWELL CK, Bekelman T, Bakre S, Jacobson LP, et al
Sociodemographic differences in parental hesitancy to the COVID-19 vaccine.
Vaccine. 2025;55:127041.
- FRIVOLD C, Giersing B, Amorij JP, Mvundura M, et al
Identification of potential vaccines for use with microarray patches in low- and
middle-income countries: An assessment from the Vaccine Innovation Prioritisation
Strategy Alliance.
Vaccine. 2025;55:126996.
- GAGNON D, Gubany C, Ouakki M, Malo B, et al
Factors influencing acceptance of RSV immunization for newborns among pregnant
individuals: A mixed-methods study.
Vaccine. 2025;55:127062.
- TIRUNEH YM, Choi J, Cuccaro PM, Martinez J, et al
Sociodemographic and health-related predictors of COVID-19 booster uptake among
fully vaccinated adults.
Vaccine. 2025;54:127048.
- NEWBERN EC, Shoaibi A, Haynes K, Blacketer C, et al
A rapid cycle analytics framework for vaccine safety surveillance within a
real-world data network: Experience with enhanced surveillance of the Janssen
COVID-19 vaccine.
Vaccine. 2025;55:127044.
- TILMANNE A, Pirson M, Leclercq P, Van Den Bulcke J, et al
Evaluation of the costs of care for pediatric patients hospitalized for RSV: A
retrospective cohort study in Belgium.
Vaccine. 2025;55:127065.
- CENAT JM, Moshirian Farahi SMM, Dalexis RD, Xu Y, et al
Vaccine hesitancy among racially diverse parents in Canada: The important role of
health literacy, conspiracy beliefs and racial discrimination.
Vaccine. 2025;55:127049.
- JIANG J, Lam KF, Lau EHY, Yin G, et al
Estimation of trajectory of COVID-19 vaccines effectiveness against infection.
Vaccine. 2025;55:127067.
- PEREZ MARC G, Coria LM, Ceballos A, Rodriguez JM, et al
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted
RBD-based protein booster vaccines in adults previously immunized with different
vaccine platforms: A phase II/III, randomized clinical trial.
Vaccine. 2025;54:127045.
- ALVES K, Kouassi A, Plested JS, Kalkeri R, et al
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant
spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive
participants: Primary day-28 analysis of a phase 2/3 open-label study.
Vaccine. 2025;55:127046.
- PAYNE AB, Novosad S, Sung HM, Zhang Y, et al
Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated
hospitalizations among adults aged >/=18 years with end stage kidney disease -
United States, September 2023-April 2024.
Vaccine. 2025;55:127010.
- PRALL S, Lopes A
"Better to die trying": Vaccine perceptions and COVID-19 experiences in rural
Namibian pastoralists.
Vaccine. 2025;55:127061.
- LA EM, Sweeney C, Davenport E, Bunniran S, et al
Pharmacy and healthcare provider offices as convenient adult vaccination settings
in the US: Patient experiences from a survey of recently-vaccinated adults.
Vaccine. 2025;54:127057.
- LEYNS C, McClenaghan E, Rodriguez P, Nguipdop-Djomo P, et al
Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional
food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological
survey.
Vaccine. 2025;54:127104.
- ENTRICAN G, Bredell H, Charlier J, Cunningham AF, et al
Opportunities and challenges for the adoption of novel platform technologies to
develop veterinary bacterial vaccines.
Vaccine. 2025;54:127117.
- WEETS CM, Wilson R, Swadley H, Katz R, et al
Strengthening health security through routine vaccination policy: A comprehensive
analysis of childhood vaccination laws across 194 countries.
Vaccine. 2025;54:127121.
- STONER MCD, Michaels J, Stocks JB, Mancuso N, et al
Evaluating concurrency and gaps between self-report and vaccine card data for
COVID-19 vaccination.
Vaccine. 2025;54:127136.
- TAKEUCHI N, Chang B, Ishiwada N, Cho Y, et al
Nationwide population-based surveillance of invasive pneumococcal disease in
children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine
and COVID-19 pandemic.
Vaccine. 2025;54:127138.
- CARTER DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, et al
Corrigendum to "Cross-protection against H7N9 influenza strains using a
live-attenuated H7N3 virus vaccine" [Vaccine (2015) 33(1) 108-16].
Vaccine. 2025;57:127174.
- MOU J, LaSalle G, Pflugeisen C, Sherls-Jones J, et al
Practice, beliefs and intent in influenza vaccination among Hispanic patients
during the pandemic: An interventional study.
Vaccine. 2025;58:127207.
- XU J, Davoudpour S, Phillips G 2nd
Applying the health belief model (HBM) to understand COVID-19 vaccine uptake
among youth and young adults: Findings from a 6-month follow-up study in the
United States.
Vaccine. 2025;54:127002.
- MYBURGH L, Karsjens H, Blanas A, de Ligt A, et al
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate
vaccine.
Vaccine. 2025;54:126989.
- RICCI L, Fery C, Tubach F, Agrinier N, et al
Health care institutions and their physicians are the greatest promoters of
COVID-19 vaccine acceptance among health care workers.
Vaccine. 2025;54:127005.
- SKOCZYNSKA A, Golebiewska A, Wrobel-Pawelczyk I, Ronkiewicz P, et al
The direct impact of mandatory PCV10 vaccination on invasive pneumococcal disease
in Polish children.
Vaccine. 2025;54:126999.
- VEDEL JO, Furtado O, Almeida LL, Nehal KR, et al
Childhood vaccination coverages in rural Guinea-Bissau before and during the
early COVID-19 pandemic, a cohort study.
Vaccine. 2025;54:127011.
- DI CHIARA C, Karimi-Shahrbabak E, Peresin J, Farrar DS, et al
A review of Canadian online resources providing information on COVID-19
vaccination for caregivers of children aged 5-11 years.
Vaccine. 2025;54:126990.
- FUJI N, Gonzalez E, Salamone FN, Bajorski P, et al
Comparison of Streptococcus pneumoniae nasopharyngeal colonization,
serotype-specific and protein-specific antibody and cytokine levels in young
children prior to, during and post COVID-19 pandemic.
Vaccine. 2025;54:126954.
- DE SOUZA RA, Barreto FR, de Jesus Lima CCO, da Natividade MS, et al
Efficacy of BCG vaccination on incidence, severity and clinical progression of
COVID-19: A BCG-REVAC population analysis.
Vaccine. 2025;54:126911.
- DESILVA MB, Vazquez-Benitez G, Seburg EM, Henderson MSG, et al
Pregnant persons perceptions and uptake of prenatal RSV vaccine - Minnesota,
2023-2024.
Vaccine. 2025;54:126958.
- DOWGIER G, Hobbs A, Greenwood D, Shawe-Taylor M, et al
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1
in the assessment of vaccination and therapeutics.
Vaccine. 2025;54:126960.
- LEE DW, Nasir A, Elbashir S, Jani H, et al
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses
against the JN.1 sublineages of SARS-CoV-2 in mice.
Vaccine. 2025;54:126961.
- CARROLL M, Fox HB, Tran A, Chellappan G, et al
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect
against evolving variants.
Vaccine. 2025;54:126988.
- MOORE M, Anderson L, Schiffer JT, Matrajt L, et al
Durability of COVID-19 vaccine and infection induced immunity: A systematic
review and meta-regression analysis.
Vaccine. 2025;54:126966.
- CHOI J, Feelemyer J, Choe K, Lynch K, et al
Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public
health emergency.
Vaccine. 2025;55:127003.
- RASKIN N, Hiligsmann M, Luyten J, Tubeuf S, et al
Socio-demographic differences in citizen' preferences for distributing a scarce,
lifesaving resource: A case study using COVID-19 vaccine distribution in Belgium.
Vaccine. 2025;55:126997.
- HAO T, Ryan GE, Lydeamore MJ, Cromer D, et al
Predicting immune protection against outcomes of infectious disease from
population-level effectiveness data with application to COVID-19.
Vaccine. 2025;55:126987.
- HAMID S, Simeone RM, Newhams MM, Halasa N, et al
Concordance between parent-reported and documented COVID-19 vaccination status
among hospitalized children and adolescents: Implications for vaccine
effectiveness estimates, May 2021-October 2023.
Vaccine. 2025;54:126891.
- KAISER S, Kaiser S, Reis J, Marschalek R, et al
Quantification of objective concentrations of DNA impurities in mRNA vaccines.
Vaccine. 2025;55:127022.
- VACHON A, Keeshan A, Galipeau Y, Crawley AM, et al
Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop
the spread Ottawa cohort analysis.
Vaccine. 2025;55:127034.
- GOLDMAN RD, Hart RJ, Bone JN, Seiler M, et al
Adverse events among early caregivers' COVID-19 vaccination correlated inversely
with intention to vaccinate their children.
Vaccine. 2025;55:127001.
Virology
- LIU R, Song F, Sun L, Yan F, et al
Exploring the pathogenic and transmission characteristics of JN.1 in golden
hamsters based on different attack methods.
Virology. 2025;608:110548.
- CAO L, Shi S, Zhang C, Zhao C, et al
A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main
protease activity.
Virology. 2025;608:110540.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016